 |
BioWorld-International-2004-05-19
Celltech Agrees To Buyout By UCB In $2.7B Cash Deal
Celltech Agrees To Buyout By UCB In $2.7B Cash Deal
LONDON - Celltech Group plc, the UK's largest biotechnology company, has agreed to be taken over by UCB SA, of Brussels, Belgium, in an all-cash deal that values Celltech at about £1.5 billion (US$2.7 billion).
Addex Raises CHF50.5M For Development Of CNS Drugs
Addex Pharmaceuticals SA raised CHF50.5 million (US$39.6 million) in what it called Europe's largest-ever Series B financing round for a biotechnology company. (BioWorld International)